Eris Lifesciences, 540596, ERIS Share Price, Rating, Research, Analysis, Fundamental & Historical Data

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

17,599.10
40.76
1

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

19,863.72
0.58%
4.86

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

17.10
19.01
19.75

EBITDA CAGR (%)

10 Years
5 Years
3 Years

19.47
18.75
13.64

PAT CAGR (%)

10 Years
5 Years
3 Years

10.17
-0.19
-2.72

P:E (Median)

8 Years
5 Years
3 Years

27.91
29.64
44.42

P:BV (Average)

8 Years
5 Years
3 Years

6.13
5.65
5.93

EV:EBITDA (Average)

8 Years
5 Years
3 Years

20.86
20.54
21.39

Earnings Forecasts:

(Updated: 21-03-2026)

Description 2024 2025 2026 2027
Adj EPS 25.85 36.45 50.35 63.15
P/E Ratio 49.17 34.87 25.24 20.13
Revenue 2879.26 3218.55 3748 4240.1
EBITDA 1017.32 1151.05 1371.01 1576.39
Net Income 351.84 493.92 690.96 864.82
ROA 5 9.45 11.44 13.34
P/B Ratio 6.06 5.18 4.43 3.75
ROE 12.93 16.83 18.82 21.06
FCFF 769.38 -326.934 -417.67 -433.539
FCFF Yield 3.70113 -1.57273 -2.00922 -2.08555
Net Debt 2250.09 1958.96 1361.84 622.2
BVPS 209.594 245.213 286.859 338.787

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone

Description Dec 25 Dec 24 Var% Sep 25 Sep 24 Var% Jun 25 Jun 24 Var% Mar 25 Mar 24 Var%
Net Sales 315.29 399.73 -21.12% 650.50 436.56 49.01% 578.64 456.69 26.70% 404.77 341.30 18.60%
Expenses 237.94 300.16 -20.73% 353.62 293.93 20.31% 362.32 333.31 8.70% 283.80 261.91 8.36%
EBITDA 77.35 99.57 -22.32% 296.88 142.63 108.15% 216.32 123.38 75.33% 120.97 79.39 52.37%
EBIDTM 24.53% 24.91% 45.64% 32.67% 37.38% 27.02% 29.89% 23.26%
Other Income 25.07 7.79 221.82% 23.59 5.81 306.02% 22.68 5.16 339.53% 16.75 20.39 -17.85%
Interest 45.20 54.65 -17.29% 46.50 56.26 -17.35% 45.14 56.17 -19.64% 53.16 28.89 84.01%
Depreciation 38.66 46.68 -17.18% 39.30 46.16 -14.86% 37.60 45.55 -17.45% 43.38 29.14 48.87%
PBT 3.89 6.03 -35.49% 234.67 46.02 409.93% 156.26 26.82 482.62% 41.18 41.75 -1.37%
Tax 0.80 4.25 -81.18% 85.10 17.92 374.89% 56.27 9.78 475.36% 10.71 2.24 378.12%
PAT 3.09 1.78 73.60% 149.57 28.10 432.28% 99.99 17.04 486.80% 30.47 39.51 -22.88%
PATM 0.98% 0.45% 22.99% 6.44% 17.28% 3.73% 7.53% 11.58%
EPS 0.23 0.13 76.92% 10.98 2.06 433.01% 7.34 1.25 487.20% 2.24 2.90 -22.76%

Description Dec 25 Dec 24 Var% Sep 25 Sep 24 Var% Jun 25 Jun 24 Var% Mar 25 Mar 24 Var%
Net Sales 807.45 727.45 11.00% 792.41 741.17 6.91% 773.00 719.72 7.40% 705.30 550.93 28.02%
Expenses 525.84 477.14 10.21% 504.20 476.66 5.78% 496.29 469.73 5.65% 452.91 402.51 12.52%
EBITDA 281.61 250.31 12.50% 288.21 264.51 8.96% 276.71 249.99 10.69% 252.39 148.42 70.05%
EBIDTM 34.88% 34.41% 36.37% 35.69% 35.80% 34.73% 35.78% 26.94%
Other Income 0.02 4.22 -99.53% 2.81 4.55 -38.24% 2.69 1.64 64.02% 7.95 15.15 -47.52%
Interest 48.82 57.17 -14.61% 49.55 59.47 -16.68% 48.68 60.37 -19.36% 54.28 33.03 64.34%
Depreciation 70.34 81.00 -13.16% 69.08 80.38 -14.06% 70.51 75.74 -6.91% 77.25 53.80 43.59%
PBT 145.23 116.36 24.81% 172.39 129.21 33.42% 160.21 115.52 38.69% 128.81 76.74 67.85%
Tax 36.52 29.30 24.64% 38.20 32.80 16.46% 36.00 25.97 38.62% 26.52 -2.96 -
PAT 108.71 87.06 24.87% 134.19 96.41 39.19% 124.21 89.55 38.70% 102.29 79.70 28.34%
PATM 13.46% 11.97% 16.93% 13.01% 16.07% 12.44% 14.50% 14.47%
EPS 7.32 6.15 19.02% 8.82 6.73 31.05% 8.66 6.12 41.50% 6.89 5.22 31.99%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone

Description TTM Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Net Sales 1,949.20 1,697.75 1,486.71 1,330.72 1,215.73 1,108.83 1,020.23 896.54 760.60 712.90 605.48 Net Sales Growth 19.27% 14.20% 11.72% 9.46% 9.64% 8.68% 13.80% 17.87% 6.69% 17.74% Cost Of Goods Sold 613.26 499.25 280.16 236.38 199.65 198.51 164.35 132.35 115.94 135.66 116.14 Gross Profit 1,335.94 1,198.50 1,206.55 1,094.34 1,016.08 910.32 855.88 764.19 644.67 577.24 489.33 GP Margin 68.54% 70.59% 81.16% 82.24% 83.58% 82.10% 83.89% 85.24% 84.76% 80.97% 80.82% Total Expenditure 1,237.68 1,211.20 1,032.89 825.61 731.67 691.36 665.28 562.77 444.67 441.70 435.01 Power & Fuel Cost - 4.10 4.46 4.41 4.01 3.89 4.54 3.34 3.04 2.93 2.74 % Of Sales - 0.24% 0.30% 0.33% 0.33% 0.35% 0.44% 0.37% 0.40% 0.41% 0.45% Employee Cost - 361.92 331.67 252.52 220.11 207.02 191.73 166.77 130.84 116.31 122.36 % Of Sales - 21.32% 22.31% 18.98% 18.11% 18.67% 18.79% 18.60% 17.20% 16.32% 20.21% Manufacturing Exp. - 15.17 19.99 14.18 38.89 11.87 14.63 8.09 4.97 4.47 6.40 % Of Sales - 0.89% 1.34% 1.07% 3.20% 1.07% 1.43% 0.90% 0.65% 0.63% 1.06% General & Admin Exp. - 155.47 211.47 154.78 135.40 110.76 125.31 122.99 92.81 106.48 102.91 % Of Sales - 9.16% 14.22% 11.63% 11.14% 9.99% 12.28% 13.72% 12.20% 14.94% 17.00% Selling & Distn. Exp. - 147.70 140.07 137.77 98.34 109.88 131.07 125.15 95.36 72.99 82.35 % Of Sales - 8.70% 9.42% 10.35% 8.09% 9.91% 12.85% 13.96% 12.54% 10.24% 13.60% Miscellaneous Exp. - 27.59 45.07 25.57 35.28 49.43 33.64 4.09 1.71 2.85 82.35 % Of Sales - 1.63% 3.03% 1.92% 2.90% 4.46% 3.30% 0.46% 0.22% 0.40% 0.35% EBITDA 711.52 486.55 453.82 505.11 484.06 417.47 354.95 333.77 315.93 271.20 170.47 EBITDA Margin 36.50% 28.66% 30.53% 37.96% 39.82% 37.65% 34.79% 37.23% 41.54% 38.04% 28.15% Other Income 88.09 35.51 34.83 17.26 28.99 10.00 15.49 32.50 28.22 25.08 3.28 Interest 190.00 220.24 57.42 20.81 3.05 0.94 1.97 22.90 10.48 0.85 0.28 Depreciation 158.94 181.77 102.39 64.66 51.45 37.64 44.88 31.59 21.79 21.44 19.55 PBT 436.00 120.05 328.84 436.91 458.54 388.89 323.59 311.78 311.89 273.99 153.93 Tax 152.88 42.66 29.12 38.90 41.35 38.29 32.32 26.39 18.23 25.84 15.96 Tax Rate 35.06% 35.54% 8.86% 8.90% 9.02% 9.85% 9.99% 8.46% 5.85% 9.43% 10.37% PAT 283.12 77.39 299.72 398.01 417.19 350.61 291.27 285.38 293.65 248.14 137.97 PAT before Minority Interest 283.12 77.39 299.72 398.01 417.19 350.61 291.27 285.38 293.65 248.14 137.97 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 14.52% 4.56% 20.16% 29.91% 34.32% 31.62% 28.55% 31.83% 38.61% 34.81% 22.79% PAT Growth 227.57% -74.18% -24.70% -4.60% 18.99% 20.37% 2.06% -2.82% 18.34% 79.85% EPS 20.79 5.68 22.01 29.22 30.63 25.74 21.39 20.95 21.56 18.22 10.13

Description TTM Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Net Sales 3,078.16 2,893.64 2,009.15 1,685.15 1,347.04 1,211.86 1,074.06 982.16 855.60 749.50 597.02 Net Sales Growth 12.37% 44.02% 19.23% 25.10% 11.15% 12.83% 9.36% 14.79% 14.16% 25.54% Cost Of Goods Sold 780.60 713.99 380.05 352.35 258.51 238.27 171.53 153.70 141.57 133.60 98.48 Gross Profit 2,297.56 2,179.65 1,629.10 1,332.80 1,088.53 973.60 902.53 828.46 714.03 615.90 498.54 GP Margin 74.64% 75.33% 81.08% 79.09% 80.81% 80.34% 84.03% 84.35% 83.45% 82.17% 83.50% Total Expenditure 1,979.24 1,876.44 1,334.32 1,148.40 862.01 781.11 706.17 637.08 533.49 480.36 425.32 Power & Fuel Cost - 15.08 12.04 5.70 4.16 3.95 4.62 3.45 3.17 3.02 3.59 % Of Sales - 0.52% 0.60% 0.34% 0.31% 0.33% 0.43% 0.35% 0.37% 0.40% 0.60% Employee Cost - 505.09 403.82 346.16 250.18 229.30 205.69 190.66 157.32 131.22 124.67 % Of Sales - 17.46% 20.10% 20.54% 18.57% 18.92% 19.15% 19.41% 18.39% 17.51% 20.88% Manufacturing Exp. - 45.10 23.89 15.61 38.81 11.51 13.96 7.81 4.89 5.05 7.87 % Of Sales - 1.56% 1.19% 0.93% 2.88% 0.95% 1.30% 0.80% 0.57% 0.67% 1.32% General & Admin Exp. - 261.45 253.91 206.62 154.21 121.70 135.85 142.38 116.86 121.29 104.36 % Of Sales - 9.04% 12.64% 12.26% 11.45% 10.04% 12.65% 14.50% 13.66% 16.18% 17.48% Selling & Distn. Exp. - 291.05 208.45 185.16 121.39 128.70 140.99 134.82 107.67 84.32 82.75 % Of Sales - 10.06% 10.38% 10.99% 9.01% 10.62% 13.13% 13.73% 12.58% 11.25% 13.86% Miscellaneous Exp. - 44.68 52.16 36.80 34.74 47.69 33.53 4.25 2.00 1.86 82.75 % Of Sales - 1.54% 2.60% 2.18% 2.58% 3.94% 3.12% 0.43% 0.23% 0.25% 0.60% EBITDA 1,098.92 1,017.20 674.83 536.75 485.03 430.75 367.89 345.08 322.11 269.14 171.70 EBITDA Margin 35.70% 35.15% 33.59% 31.85% 36.01% 35.54% 34.25% 35.13% 37.65% 35.91% 28.76% Other Income 13.47 18.36 23.82 11.15 26.09 8.71 16.01 31.69 26.41 25.11 3.37 Interest 201.33 231.29 84.80 26.17 4.22 1.98 2.30 23.06 10.65 1.10 0.28 Depreciation 287.18 315.46 182.51 117.09 64.70 42.98 50.26 36.35 25.64 22.76 20.36 PBT 606.64 488.81 431.34 404.64 442.20 394.50 331.35 317.36 312.23 270.39 154.44 Tax 137.24 114.20 34.22 30.48 36.41 39.36 34.84 26.21 17.25 23.78 19.59 Tax Rate 22.62% 23.36% 7.93% 7.53% 8.23% 9.98% 10.51% 8.26% 5.52% 8.79% 12.68% PAT 469.40 351.84 392.05 382.16 406.11 355.13 296.50 290.80 294.11 246.79 133.57 PAT before Minority Interest 430.39 374.67 397.12 374.16 405.79 355.13 296.51 291.15 294.98 246.61 134.86 Minority Interest -39.01 -22.83 -5.07 8.00 0.32 0.00 -0.01 -0.35 -0.87 0.18 -1.29 PAT Margin 15.25% 12.16% 19.51% 22.68% 30.15% 29.30% 27.61% 29.61% 34.37% 32.93% 22.37% PAT Growth 33.08% -10.26% 2.59% -5.90% 14.36% 19.77% 1.96% -1.13% 19.17% 84.76% EPS 34.46 25.83 28.78 28.06 29.82 26.07 21.77 21.35 21.59 18.12 9.81

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Shareholder's Funds 2,514.90 2,524.02 2,221.88 1,918.56 1,575.47 1,299.70 1,156.01 868.18 574.60 305.73 Share Capital 13.62 13.60 13.60 13.59 13.58 13.58 13.75 13.75 13.75 0.14 Total Reserves 2,491.12 2,505.36 2,205.48 1,903.07 1,557.91 1,283.27 1,141.06 854.43 560.85 305.59 Non-Current Liabilities 1,430.23 259.97 4.22 -170.49 -161.81 -130.18 -114.05 196.33 -22.95 20.17 Secured Loans 1,632.64 485.94 209.47 0.00 0.00 0.00 0.00 273.69 0.00 0.00 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Long Term Provisions 57.98 40.56 31.03 28.84 29.14 24.13 16.47 15.02 19.80 23.10 Current Liabilities 1,010.95 2,322.55 361.73 249.79 212.42 203.06 360.46 277.88 114.26 70.81 Trade Payables 216.08 109.63 83.07 96.77 86.71 89.93 74.93 79.03 25.11 27.89 Other Current Liabilities 376.44 721.86 83.43 26.61 23.37 24.41 195.04 112.61 12.39 8.47 Short Term Borrowings 356.50 1,387.61 55.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Short Term Provisions 61.93 103.45 140.22 126.41 102.34 88.72 90.50 86.24 76.76 34.44 Total Liabilities 4,956.08 5,106.54 2,587.83 1,997.86 1,626.08 1,372.58 1,402.42 1,342.39 665.91 396.71 Net Block 2,412.18 1,515.56 897.81 642.00 584.32 600.64 483.85 489.75 91.78 64.79 Gross Block 2,875.21 1,811.21 1,094.83 783.40 716.88 695.65 551.80 532.93 113.20 108.20 Accumulated Depreciation 463.03 295.65 197.01 141.40 132.55 95.01 67.96 43.19 21.43 43.41 Non Current Assets 4,311.53 3,169.24 1,957.80 1,334.30 1,134.47 869.37 782.82 958.53 399.30 159.69 Capital Work in Progress 0.27 0.61 0.34 2.98 1.55 4.37 2.73 0.00 0.00 0.00 Non Current Investment 991.27 1,618.95 966.51 678.18 480.97 246.03 274.36 451.84 290.43 62.59 Long Term Loans & Adv. 268.64 27.04 85.95 11.13 25.36 15.44 16.00 10.95 12.19 32.30 Other Non Current Assets 639.17 7.08 7.17 0.00 42.27 2.88 5.88 6.00 4.91 0.00 Current Assets 644.55 1,937.30 630.03 663.56 491.60 503.22 619.60 383.86 266.61 237.02 Current Investments 0.00 0.00 30.00 99.55 50.40 74.27 306.11 93.76 90.18 143.73 Inventories 191.25 91.63 63.70 84.79 64.85 65.46 74.70 57.52 47.20 49.46 Sundry Debtors 236.19 239.97 229.22 137.56 113.76 140.82 75.90 60.50 41.30 25.36 Cash & Bank 92.46 1,296.73 47.65 46.10 32.66 64.95 6.47 8.81 2.06 8.53 Other Current Assets 124.65 25.00 17.47 20.97 229.95 157.71 156.42 163.28 85.87 9.94 Short Term Loans & Adv. 104.35 283.97 241.99 274.60 204.25 109.46 103.14 123.50 82.40 7.81 Net Current Assets -366.40 -385.25 268.30 413.77 279.18 300.16 259.13 105.98 152.35 166.21 Total Assets 4,956.08 5,106.54 2,587.83 1,997.86 1,626.07 1,372.59 1,402.42 1,342.39 665.91 396.71

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Shareholder's Funds 2,854.36 2,586.18 2,195.99 1,908.31 1,576.42 1,296.33 1,150.52 861.31 567.14 299.62 Share Capital 13.62 13.60 13.60 13.59 13.58 13.58 13.75 13.75 13.75 0.14 Total Reserves 2,830.65 2,567.56 2,179.59 1,892.82 1,558.87 1,279.90 1,135.57 847.56 553.39 299.49 Non-Current Liabilities 2,100.97 979.35 730.02 -78.80 -109.06 -79.63 -65.50 248.09 11.82 19.84 Secured Loans 1,737.51 654.51 644.45 45.00 0.00 0.00 0.29 274.19 0.49 0.00 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Long Term Provisions 78.97 52.72 44.67 32.16 31.47 25.98 19.39 18.71 22.96 23.10 Current Liabilities 1,489.55 2,608.96 521.18 283.34 235.45 220.17 377.25 293.98 129.27 68.95 Trade Payables 332.35 218.93 124.77 117.77 102.62 100.05 84.13 90.77 38.52 24.57 Other Current Liabilities 530.75 900.18 190.12 35.81 29.07 27.44 198.57 115.06 13.52 9.71 Short Term Borrowings 396.59 1,311.31 55.01 0.01 0.01 0.00 0.00 0.00 0.00 0.00 Short Term Provisions 229.86 178.54 151.29 129.75 103.76 92.68 94.55 88.15 77.24 34.67 Total Liabilities 6,862.28 6,810.40 3,471.88 2,112.74 1,702.81 1,436.87 1,480.58 1,428.04 732.02 391.61 Net Block 5,306.48 4,319.16 2,568.10 917.94 853.87 874.85 760.54 771.09 231.65 71.37 Gross Block 6,060.83 4,772.87 2,843.17 1,091.96 1,005.79 983.89 838.26 819.52 254.43 123.31 Accumulated Depreciation 754.35 453.71 275.07 174.02 151.92 109.04 77.73 48.42 22.78 51.95 Non Current Assets 5,531.13 4,431.47 2,629.21 1,401.72 1,167.24 901.78 827.09 1,060.81 462.52 169.38 Capital Work in Progress 67.01 19.67 21.72 26.99 1.55 4.37 2.73 0.00 0.07 0.00 Non Current Investment 62.00 15.55 6.69 420.84 243.65 3.20 40.91 271.61 213.05 62.60 Long Term Loans & Adv. 88.29 69.83 25.32 35.94 25.90 16.47 17.03 12.11 12.84 35.41 Other Non Current Assets 7.35 7.26 7.37 0.00 42.27 2.88 5.88 6.00 4.91 0.00 Current Assets 1,331.15 2,378.93 842.67 711.02 535.56 535.10 653.49 367.23 269.50 222.24 Current Investments 5.00 0.00 30.01 99.55 50.40 74.78 314.94 93.76 90.18 127.44 Inventories 334.83 189.03 131.44 117.91 94.47 69.47 82.65 65.45 55.82 47.62 Sundry Debtors 458.64 422.00 292.71 160.97 140.49 156.88 83.98 66.64 48.86 25.37 Cash & Bank 222.83 1,400.64 58.46 52.33 38.28 67.33 7.51 10.64 2.42 9.69 Other Current Assets 309.85 32.14 22.42 24.04 211.94 166.63 164.41 130.74 72.22 12.11 Short Term Loans & Adv. 282.57 335.12 307.65 256.23 175.70 111.48 106.85 86.48 68.48 9.85 Net Current Assets -158.40 -230.03 321.49 427.68 300.12 314.93 276.24 73.25 140.22 153.29 Total Assets 6,862.28 6,810.40 3,471.88 2,112.74 1,702.80 1,436.88 1,480.58 1,428.04 732.02 391.62

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Cash From Operating Activity 701.86 336.29 322.33 369.41 395.41 265.25 216.31 236.28 209.72 132.65 PBT 120.05 328.83 436.91 458.54 388.89 323.59 311.78 311.89 273.99 153.93 Adjustment 393.56 144.12 73.70 31.04 36.11 39.36 24.57 7.63 -0.90 17.81 Changes in Working Capital 201.69 -63.18 -110.50 -37.26 38.44 -47.37 -50.18 -15.57 -11.17 -7.53 Cash after chg. in Working capital 715.30 409.77 400.11 452.31 463.44 315.59 286.17 303.95 261.92 164.21 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -13.44 -73.48 -77.79 -82.90 -68.03 -50.34 -69.86 -67.67 -52.21 -31.55 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -358.99 -2,491.89 -513.30 -267.64 -347.86 126.74 2.08 -592.73 -198.67 -45.39 Net Fixed Assets -1,063.66 -716.65 -308.79 -67.95 -18.41 -145.49 -21.60 -419.73 -5.00 -22.68 Net Investments 627.68 -622.44 -218.78 -246.36 -211.07 260.17 -34.87 -164.99 -174.29 -24.03 Others 76.99 -1,152.80 14.27 46.67 -118.38 12.06 58.55 -8.01 -19.38 1.32 Cash from Financing Activity -310.46 2,160.05 193.75 -88.42 -81.13 -333.52 -220.74 363.26 -17.52 -83.70 Net Cash Inflow / Outflow 32.41 4.45 2.78 13.36 -33.58 58.47 -2.34 6.81 -6.48 3.57 Opening Cash & Equivalents 51.93 47.48 44.70 31.35 64.93 6.46 8.81 2.00 8.48 4.91 Closing Cash & Equivalent 84.34 51.93 47.48 44.70 31.35 64.93 6.46 8.81 2.00 8.48

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Cash From Operating Activity 1,065.01 486.01 291.74 378.26 375.36 271.17 223.00 234.63 200.21 131.48 PBT 488.87 431.34 404.64 442.20 394.50 331.35 317.36 312.23 270.39 154.44 Adjustment 548.05 254.16 139.84 49.25 44.07 44.24 30.50 14.12 -0.65 19.92 Changes in Working Capital 125.97 -98.74 -175.54 -29.90 5.33 -52.65 -53.24 -22.15 -16.45 -8.21 Cash after chg. in Working capital 1,162.89 586.76 368.95 461.55 443.90 322.94 294.62 304.20 253.29 166.16 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -97.88 -100.75 -77.21 -83.28 -68.53 -51.77 -71.63 -69.56 -53.08 -34.68 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -79.97 -1,854.52 -982.10 -319.61 -323.36 123.23 -5.05 -590.10 -184.46 -43.91 Net Fixed Assets -1,063.66 -716.65 -308.79 -67.95 -18.41 -145.49 -21.60 -419.73 -5.00 -22.68 Net Investments 627.68 -622.44 -218.78 -246.36 -211.07 260.17 -34.87 -164.99 -174.29 -24.03 Others 356.01 -515.43 -454.53 -5.30 -93.88 8.55 51.42 -5.38 -5.17 2.80 Cash from Financing Activity -881.32 1,379.68 688.02 -44.70 -82.39 -334.59 -221.05 363.21 -23.66 -83.70 Net Cash Inflow / Outflow 103.72 11.17 -2.34 13.96 -30.39 59.81 -3.11 7.75 -7.91 3.87 Opening Cash & Equivalents 94.25 56.02 50.87 36.91 67.31 7.50 10.61 2.34 8.87 5.00 Closing Cash & Equivalent 199.74 94.15 56.02 50.87 36.91 67.31 7.50 10.61 2.34 8.87

Financial Ratios

Consolidated /

Standalone

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Book Value (Rs.) 183.90 185.22 163.18 141.00 115.74 95.51 83.97 63.14 41.79 22154.28 ROA 1.54% 7.79% 17.36% 23.02% 23.38% 20.99% 20.79% 29.24% 46.70% 36.93% ROE 3.08% 12.65% 19.25% 23.92% 24.45% 23.76% 28.21% 40.71% 56.37% 48.12% ROCE 6.96% 10.18% 20.54% 26.42% 27.12% 24.74% 25.98% 35.45% 62.40% 53.64% Fixed Asset Turnover 0.74 1.08 1.46 1.67 1.61 1.64 1.65 2.35 6.44 6.43 Receivable days 50.04 54.81 48.81 36.56 40.89 38.77 27.76 24.43 17.07 14.34 Inventory Days 29.73 18.15 19.76 21.77 20.93 25.07 26.92 25.13 24.74 30.25 Payable days 119.06 125.53 138.85 167.72 162.39 56.42 58.45 51.57 30.40 33.54 Cash Conversion Cycle -39.30 -52.57 -70.28 -109.39 -100.57 7.42 -3.77 -2.02 11.41 11.05 Total Debt/Equity 0.88 1.00 0.14 0.00 0.00 0.00 0.15 0.43 0.00 0.00 Interest Cover 1.55 6.73 22.00 151.29 416.49 165.51 14.61 30.77 321.83 556.69

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Book Value (Rs.) 208.83 189.79 161.28 140.25 115.81 95.26 83.58 62.64 41.25 21711.81 ROA 5.48% 7.72% 13.40% 21.27% 22.62% 20.33% 20.02% 27.31% 43.89% 36.17% ROE 13.81% 16.64% 18.25% 23.33% 24.78% 24.28% 28.96% 41.30% 56.90% 47.68% ROCE 13.59% 12.37% 17.30% 25.29% 27.60% 25.44% 26.54% 35.76% 62.56% 54.56% Fixed Asset Turnover 0.55 0.56 0.90 1.33 1.25 1.18 1.18 1.59 3.97 5.42 Receivable days 54.07 61.68 46.91 39.44 43.59 40.93 27.99 24.64 18.07 14.56 Inventory Days 32.16 27.66 25.78 27.78 24.03 25.85 27.52 25.87 25.19 31.24 Payable days 140.91 165.04 125.63 155.58 155.23 59.47 59.07 54.07 32.17 33.59 Cash Conversion Cycle -54.68 -75.70 -52.94 -88.36 -87.61 7.30 -3.57 -3.57 11.09 12.21 Total Debt/Equity 0.85 1.06 0.38 0.02 0.00 0.00 0.15 0.44 0.00 0.00 Interest Cover 3.11 6.09 16.46 105.81 200.75 145.25 14.76 30.31 246.14 558.56

Top Investors:

lilac investments limited

hdfc small cap fund

franklin india small cap fund

hetal rasiklal shah

uti-flexi cap fund

bhikhalal chimanlal shah

rakesh shah

llp

Annual Reports:

News Update:

Eris Lifesciences to launch generic Semaglutide under brand ‘SUNDAE’ in India
21st Mar 2026, 12:03 PM

The company is introducing SUNDAE in multi-dose vial formats at highly accessible pricing starting at Rs 1,290 per month
Read More
Eris Lifesciences inks pact with Natco Pharma for commercialisation of Semaglutide in India
24th Feb 2026, 14:39 PM

The addition of semaglutide is expected to further strengthen Eris’ portfolio in advanced diabetes therapies
Read More
Eris Lifesciences - Quarterly Results
14th Feb 2026, 00:00 AM

Read More

Eris Lifesciences Ltd.

Pharmaceuticals & Drugs - Domestic

BSE: 540596 | NSE: ERIS

Stock Summary

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

EBITDA CAGR (%)

PAT CAGR (%)

P:E (Median)

P:BV (Average)

EV:EBITDA (Average)

Earnings Forecasts:

Quarterly Results

Consolidated Figures in Rs. Crores /

Annual Results

Consolidated Figures in Rs. Crores /

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Cash Flow

Consolidated Figures in Rs. Crores /

Financial Ratios

Consolidated /

Top Investors:

Annual Reports:

News Update:

Eris Lifesciences Ltd.

Pharmaceuticals & Drugs - Domestic

BSE: 540596 | NSE: ERIS

Stock Summary

Shareholding Pattern

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

EBITDA CAGR (%)

PAT CAGR (%)

P:E (Median)

P:BV (Average)

EV:EBITDA (Average)

Earnings Forecasts:

Quarterly Results

Consolidated Figures in Rs. Crores /

Annual Results

Consolidated Figures in Rs. Crores /

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Cash Flow

Consolidated Figures in Rs. Crores /

Financial Ratios

Consolidated /

Top Investors:

Annual Reports:

News Update: